Libtayo® (cemiplimab) Approved in the European Union as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with High Risk of ...

Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free ...
The Healthy @Reader's Digest on MSN

8 Symptoms of Colon Polyps

"Not all colon polyps are cancerous but all colon cancer starts as a polyp which is why everyone needs to know about them and ...
Becker's ASC

10 things to know about the rise in colonoscopies

As screening guidelines evolve and GI care increasingly shifts to outpatient settings, ASCs are seeing significant growth in colonoscopy volume. Here are ten developments shaping that trend: ...